China gives conditional approval to Sinopharm vaccine

4



BEIJING (AP) – China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm.

The vaccine is the first one approved for general use in China.

Chen Shifei, the deputy commissioner of China’s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night.

The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that trials had shown it to be 79.3% effective.

Sign up for Daily Newsletters

Copyright © 2020 The Washington Times, LLC.





View original
Post

LEAVE A REPLY

Please enter your comment!
Please enter your name here